seed
Stage
1
Investors
About
Madorra develops a non-hormonal, noninvasive medical device to treat moderate to severe vulvovaginal atrophy, targeting post-menopausal people and breast cancer survivors, with FDA breakthrough device designation.
Explore Madorra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.